Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 9/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GALK1 | P51570 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RARA | P10276 | 1/20 | 0.38 |
| ▸ | GCGR | P47871 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710123 | 0.92 | ABL1 (0.43) | ABL1THRBTRPV1MEN1GALK1 | |
| SCHEMBL6707775 | 0.90 | ABL1 (0.42) | ABL1THRBTRPV1MEN1GALK1 | |
| SCHEMBL6711769 | 0.85 | GCGR (0.41) | ABL1RXFP1THRBTRPV1GCGR | |
| SCHEMBL6713555 | 0.84 | RXFP1 (0.46) | RXFP1THRBMEN1KMT2ANPC1 | |
| SCHEMBL6711779 | 0.84 | RXFP1 (0.43) | RXFP1MEN1KMT2AMAPTNPC1 | |
| SCHEMBL6710208 | 0.83 | RXFP1 (0.44) | ABL1RXFP1THRBMEN1KMT2A | |
| SCHEMBL6710122 | 0.83 | MEN1 (0.42) | RXFP1MEN1KMT2AMAPTNPC1 | |
| SCHEMBL6713186 | 0.82 | RXFP1 (0.42) | RXFP1 | |
| SCHEMBL6708544 | 0.81 | ALDH1A1 (0.47) | RXFP1MEN1KMT2AMAPTNPC1 | |
| SCHEMBL6711593 | 0.81 | RXFP1 (0.43) | RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | ABL1 344/4885RXFP1 3836/4885THRB 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.